Artificial Intelligence and Wearable Integration
Cardiovascular care in 2026 is no longer limited to the clinic. The integration of consumer wearables with medical-grade diagnostics has created a continuous loop of patient data.
Smartwatch ECGs: Consumer devices now possess FDA-cleared algorithms for detecting Atrial Fibrillation and, in some emerging models, identifying signs of early myocardial ischemia.
Predictive Diagnostics: AI platforms now ingest data from pacemakers and VADs to predict cardiac events up to 30 days in advance. By analyzing subtle changes in heart rate variability and fluid levels, these systems provide a "probabilistic" view of a patient’s heart health.
1 View